Fatigue in Patients with Myasthenia Gravis. A Systematic Review of the Literature.

Myasthenia Gravis (MG) is a chronic autoimmune disease (AID) with a prevalence of 1-2 per 10.000 [1]. The clinical hallmark is fluctuating weakness of striated muscles with antibodies directly affecting the neuromuscular junction. In approximately 85% of patients, the initial presenting symptoms are asymmetric ptosis and/or diplopia. Approximately 80% of initially ocular MG patients will develop generalized MG within two years of disease onset [2].

Source: Neuromuscular Disorders - June 30, 2020 Category: Neurology Authors: Annabel M. Ruiter, Jan J.G.M. Verschuuren, Martijn R. Tannemaat Tags: Systematic review article Source Type: research